Literature DB >> 24013691

Expansion of donor-reactive host T cells in primary graft failure after allogeneic hematopoietic SCT following reduced-intensity conditioning.

M Koyama1, D Hashimoto2, K Nagafuji3, T Eto4, Y Ohno5, K Aoyama6, H Iwasaki7, T Miyamoto6, G R Hill8, K Akashi9, T Teshima2.   

Abstract

Graft rejection remains a major obstacle in allogeneic hematopoietic SCT following reduced-intensity conditioning (RIC-SCT), particularly after cord blood transplantation (CBT). In a murine MHC-mismatched model of RIC-SCT, primary graft rejection was associated with activation and expansion of donor-reactive host T cells in peripheral blood and BM early after SCT. Donor-derived dendritic cells are at least partly involved in host T-cell activation. We then evaluated if such an expansion of host T cells could be associated with graft rejection after RIC-CBT. Expansion of residual host lymphocytes was observed in 4/7 patients with graft rejection at 3 weeks after CBT, but in none of the 17 patients who achieved engraftment. These results suggest the crucial role of residual host T cells after RIC-SCT in graft rejection and expansion of host T cells could be a marker of graft rejection. Development of more efficient T cell-suppressive conditioning regimens may be necessary in the context of RIC-SCT.

Entities:  

Mesh:

Year:  2013        PMID: 24013691     DOI: 10.1038/bmt.2013.134

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  48 in total

1.  Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice.

Authors:  Shoji Asakura; Daigo Hashimoto; Shuichiro Takashima; Haruko Sugiyama; Yoshinobu Maeda; Koichi Akashi; Mitsune Tanimoto; Takanori Teshima
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

2.  Coexistent naïve phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood.

Authors:  Paul Szabolcs; Kyung-Duk Park; Melissa Reese; Luciana Marti; Gloria Broadwater; Joanne Kurtzberg
Journal:  Exp Hematol       Date:  2003-08       Impact factor: 3.084

3.  MiHA reactive CD4 and CD8 T-cells effect resistance to hematopoietic engraftment following reduced intensity conditioning.

Authors:  Z F Zimmerman; R B Levy
Journal:  Am J Transplant       Date:  2006-06-22       Impact factor: 8.086

4.  Cord blood T lymphocytes lack constitutive perforin expression in contrast to adult peripheral blood T lymphocytes.

Authors:  C Berthou; S Legros-Maïda; A Soulié; A Wargnier; J Guillet; C Rabian; E Gluckman; M Sasportes
Journal:  Blood       Date:  1995-03-15       Impact factor: 22.113

5.  Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program.

Authors:  S M Davies; C Kollman; C Anasetti; J H Antin; J Gajewski; J T Casper; A Nademanee; H Noreen; R King; D Confer; N A Kernan
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

6.  Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection.

Authors:  J Dubovsky; H Daxberger; G Fritsch; D Printz; C Peters; S Matthes; H Gadner; T Lion; N Muller-Bérat
Journal:  Leukemia       Date:  1999-12       Impact factor: 11.528

7.  Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years.

Authors:  Raymond Wong; Sergio A Giralt; Thomas Martin; Daniel R Couriel; Athanasios Anagnostopoulos; Chitra Hosing; Borje S Andersson; Pedro Cano; Munir Shahjahan; Cindy Ippoliti; Elihu H Estey; John McMannis; James L Gajewski; Richard E Champlin; Marcos de Lima
Journal:  Blood       Date:  2003-07-03       Impact factor: 22.113

8.  A novel CD11c.DTR transgenic mouse for depletion of dendritic cells reveals their requirement for homeostatic proliferation of natural killer cells.

Authors:  Kristin Hochweller; Jörg Striegler; Günter J Hämmerling; Natalio Garbi
Journal:  Eur J Immunol       Date:  2008-10       Impact factor: 5.532

9.  Characterization of acute bone marrow graft rejection in T cell-depleted, partially mismatched related donor bone marrow transplantation.

Authors:  L S Lamb; F Szafer; P J Henslee-Downey; M Walker; S King; K Godder; A R Pati; R Best; L Steinman; S S Geier
Journal:  Exp Hematol       Date:  1995-12       Impact factor: 3.084

10.  Intracellular cytokine profile of cord and adult blood lymphocytes.

Authors:  I M Chalmers; G Janossy; M Contreras; C Navarrete
Journal:  Blood       Date:  1998-07-01       Impact factor: 22.113

View more
  7 in total

1.  Feasibility of salvage cord blood transplantation following fludarabine, melphalan and low-dose TBI for graft rejection after hematopoietic stem cell transplantation.

Authors:  K Ishiyama; J Takeda; T Kondo; N Sugimoto; H Kawabata; T Kitano; A Takaori-Kondo
Journal:  Bone Marrow Transplant       Date:  2016-02-15       Impact factor: 5.483

2.  Integration of humoral and cellular HLA-specific immune responses in cord blood allograft rejection.

Authors:  R Hanajiri; M Murata; K Sugimoto; M Murase; R Sakemura; T Goto; K Watanabe; N Imahashi; S Terakura; H Ohashi; Y Akatsuka; S Kurahashi; K Miyamura; H Kiyoi; T Nishida; T Naoe
Journal:  Bone Marrow Transplant       Date:  2015-06-01       Impact factor: 5.483

3.  Feasibility of salvage cord blood transplantation using a fludarabine, melphalan, and low-dose anti-thymocyte globulin conditioning regimen.

Authors:  Takumi Hoshino; Satoru Takada; Nahoko Hatsumi; Toru Sakura
Journal:  Int J Hematol       Date:  2019-02-08       Impact factor: 2.490

4.  Increase of bone marrow macrophages and CD8+ T lymphocytes predict graft failure after allogeneic bone marrow or cord blood transplantation.

Authors:  N Kawashima; S Terakura; S Nishiwaki; D Koyama; Y Ozawa; M Ito; K Miyamura
Journal:  Bone Marrow Transplant       Date:  2017-04-03       Impact factor: 5.483

5.  GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia.

Authors:  S Terakura; Y Kuwatsuka; S Yamasaki; A Wake; J Kanda; Y Inamoto; S Mizuta; T Yamaguchi; N Uchida; Y Kouzai; N Aotsuka; H Ogawa; H Kanamori; K Nishiwaki; S Miyakoshi; M Onizuka; I Amano; T Fukuda; T Ichinohe; Y Atsuta; M Murata; T Teshima
Journal:  Bone Marrow Transplant       Date:  2017-06-12       Impact factor: 5.483

6.  Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation.

Authors:  Pietro Merli; Ignazio Caruana; Rita De Vito; Luisa Strocchio; Gerrit Weber; Francesca Del Bufalo; Vanessa Buatois; Paolo Montanari; Maria Giuseppina Cefalo; Angela Pitisci; Mattia Algeri; Federica Galaverna; Concetta Quintarelli; Valentina Cirillo; Daria Pagliara; Walter Ferlin; Maria Ballabio; Cristina De Min; Franco Locatelli
Journal:  Haematologica       Date:  2019-02-21       Impact factor: 9.941

7.  Cord-Blood Engraftment Using an Enhanced Dual-Conditioning Regimen for Malignant Hematologic Diseases.

Authors:  Jiahua Ding; Yongjun Fang; Rongfu Zhou; Yan Gu; Shengnan Du; Qin Lu; Qingqing Yue
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.